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Abstract
Background: N-methyl-D-Aspartate (NMDA) and its receptors (NMDAR) play a critical
role in glutamatergic neurotransmission. Ethanol molecules inhibit these receptors, and
if the brain is exposed to ethanol chronically, NMDA-induced glutamatergic changes
can result in physical dependence to ethanol in order to sustain normal brain function.
In these cases, removal of ethanol from the system results in excitotoxic withdrawal.
One compensatory mechanism the brain uses to regulate extracellular glutamate
concentration is modulating the number of NMDARs at the synapse. Previous work has
shown that the number of functional NMDARs at the synapse can be changed by three
mechanisms: additional receptors can be synthesized and inserted, receptors can be
recruited to the synapse from extrasynaptic regions, or the functionality of existing
receptors can be modified.
Methods: In this study, we consider the dynamic relocation control of NMDARs in
response to chronic alcoholism and withdrawal. Specifically, we (1) propose and
construct a mathematical model of the relocation control as a negative feedback
system with an explicit set point, (2) investigate the effect of various ethanol
consumption and withdrawal profiles on the NMDAR population, and (3) propose and
calculate quantitative measures for the extent of withdrawal based on modeled
NMDAR populations.
Results: A relocation-only model with an explicit set point was developed. The
model was shown to apply across a wide range of controller parameters. The
results suggest that withdrawal severity does not depend upon the dynamics
involved in the development of dependence, and that regulating the blood alcohol
level throughout the progression of withdrawal can minimize excitotoxic
withdrawal symptoms.
Conclusions: The negative feedback control system produced characteristic behaviors
of NMDAR populations in response to simulations of alcohol dependence and abrupt
withdrawal. The model can also predict the severity of excitotoxic withdrawal following
various alcohol consumption and/or withdrawal patterns in order to generate testable
hypotheses regarding ameliorating withdrawal.
Keywords: Alcohol dependence, Alcohol withdrawal, Control system modeling, NMDA
receptors, Glutamatergic signaling
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Background
Chronic alcoholism develops when individuals regularly consume pharmacologically
significant quantities of ethanol over an extended period of time. The constant pres-
ence of ethanol leads to homeostatic adaptations in the brain and its neurotransmit-
ter systems to compensate for the neurological effects of ethanol. Given enough
time, this can lead to a state where the brain is physically dependent upon ethanol
to function [1]; that is to say that the brain does not function appropriately without
a high concentration of ethanol in the bloodstream. Once dependence has devel-
oped, if the individual ceases to consume alcohol, they may experience symptoms of
withdrawal. These symptoms imply a dysregulation of the body’s internal equilib-
rium or homeostasis, and can manifest both physiologically and emotionally.
Studies have implicated neuroexcitatory transmitter systems as part of the neuro-
logical response to ethanol [2,3], the homeostatic development of dependence [4-6],
withdrawal symptoms [7-9], and behavior [10]. The dynamic regulation and distur-
bances that affect excitatory neurotransmission are of fundamental importance to
understanding the mechanisms behind the development of and withdrawal from
ethanol dependence. Of particular interest is the ionotropic N-methyl-D-aspartate
(NMDA) receptor (NMDAR). NMDARs are selectively targeted by ethanol and are
an important neurochemical component of dependence and withdrawal [5,11-13]. It
has been hypothesized that long-term alcohol abuse leads to mal-adaptive alter-
ations and dysregulation of NMDARs in an attempt to maintain glutamatergic
homeostasis [1,5,10,12-15]. These adaptations are such that normal function is only
possible in the presence of ethanol [14], and the subsequent cascade of neurotrans-
mitters may be one mechanism by which the physical [1,5,14,15] and behavioral
symptoms [10,12,13] of ethanol dependence and withdrawal are manifested.
Interestingly, the number, composition, and location of NMDARs in neurons are
not static [16,17], but rather respond to changes in neuronal activity and sensory
stimuli in a dynamic manner. It has been suggested that short-term inhibition leads
to rapid changes in activity that are dependent on the phosphorylation of NR2 sub-
units by striatal-enriched tyrosine phosphatase [18-20]. Long-term exposure to etha-
nol instead results in chronic glutamatergic inhibition and has been shown to lead to
compensatory increases in the number, density, and composition of NMDARs at a
cellular and synaptic level [3,5,6,21-23]. These compensatory changes in the subunit
composition and the quantity of receptors at the surface of the neuron have been
shown to be controlled by three activity-dependent mechanisms: insertion, internal-
ization, and lateral movement [17]. Additional receptors may be synthesized and
inserted at the synapse [17]. Alternatively, additional receptors may be recruited from
some pool of available receptors, either from within the cell or from the local extra-
cellular region [7,24]. These conceptualizations are supported by an observed increase
in NR2B subunit mRNA as a response to ethanol treatment [2,21] and an increase in
NR1 subunit polypeptide levels in response to chronic ethanol exposure despite un-
changed levels of mRNA [25].
When ethanol is removed from the system and the ethanol-induced inhibitory ef-
fects decay, overstimulation of NMDARs and subsequent excitotoxic hyperactivity are
observed [1,26]. This excessive stimulation can result in a cascade of events that lead
to excitotoxic cell death, delayed neuronal degeneration, withdrawal seizures, and
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increased activity and sensitivity of NMDARs [7,23,27]. Introduction of NMDA dur-
ing this withdrawal period exacerbates the stimulation of NMDARs and also the seiz-
ure symptoms, while antagonists like Dizocilpine (MK-801) and ethanol decrease the
frequency of seizures [28,29].
We posit that the neuroadaptive changes in composition, function, and quantity
of NMDARs are controlled by a negative feedback loop in which glutamatergic ac-
tivity is maintained by changes in the number of NMDARs at the synapse. When
regularly exposed to pharmacologically active concentrations of ethanol, this control
leads to increased tolerance for and dependence on ethanol in order to achieve nor-
mal brain function [8]. In our previous work, we developed a mathematical model
of a synthesis-only negative feedback control hypothesis [30,31] in which the
NMDAR population could only be controlled by synthesizing and inserting new re-
ceptors at the synapse. However, recent experimental evidence suggests that recep-
tor synthesis cannot explain the dynamic regulation of NMDA receptors [24,32].
Therefore, this study focuses on the development and implementation of a mathem-
atical representation of a relocation-based control scheme in which neuronal activ-
ity is controlled by movement of receptors to and from the synapse and
extrasynaptic regions. Ultimately, we evaluate the severity of predicted withdrawal
following various alcohol consumption patterns in order to generate testable
hypotheses.
Results and Discussion
A control system model of NMDAR regulation
In the hopes of better understanding biological responses to alcohol dependence
and withdrawal at a systemic level, we developed a mathematical model to describe
the dynamics of NMDARs in response to ethanol where we considered the excita-
tory neurotransmission process as a negative feedback control system. As described
in the Methods section, we propose a composite controller with two active compo-
nents: an activity controller that maintains synaptic activity by sending additional
receptors to the synapse, and a density controller that moderates the population of
NMDARs at the synapse by removing active, unblocked receptors from the synapse.
Together, these controllers function to maintain a constant number of active synap-
tic receptors in the face of disturbances, such as inhibition of receptors by ethanol.
When simulated with the alcohol profile given in Equation 15 (Figure 1A), the
model described in the Methods section with Parameter Set A (Table 1) produced re-
sults (Figure 1) that are qualitatively consistent with experimental data in four dis-
tinct ways: (1) the synaptic NMDAR population increases with alcohol (Figure 1C)
[2,3,5,7,17,21,28,29]; (2) alcohol consumption paradigms affect the severity of out-
comes [3,33]; (3) an excitotoxic withdrawal response is observed [1,4,7,13]; and (4)
NMDAR populations return to normal levels over time [28].
Here, the explicit set point was fixed at an arbitrary value of 100 NMDARs at the
synapse, as indicated by the dashed line in Figure 1C. As alcohol molecules block
the active, unblocked receptors, the composite controller attempts to maintain the
set point value by receptor translocation to (activity controller, dark red) and from
(density controller, navy blue) the extrasynaptic pool of receptors (Figure 1B).
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A tunable composite controller
The proposed composite controller consists of six primary parameters: ymax1, n1, a1(A),
ymax2, n2, and a2, where a1 is a function of alcohol concentration involving three second-
ary parameters: ax, az, and ka (Equations 10–12). The steady state controller activity varies
with changes in the primary parameters as shown in Figure 2. Increases in alcohol con-
centration enhance the actions of the activity controller through its effect on a1 (Equa-
tion 12). This provides a mechanism for incorporating alterations in the apparent set
point during long-term exposure to alcohol, which is one hypothesis for the development
of alcohol dependence [1,7,8,21,25].
Clinical reports suggest a wide variety among individuals’ neuroexcitatory activity during
alcohol dependence and withdrawal based on genetics [34], gender [3], and behavior [33].
Our composite controller is tunable to approximate a range of activity. Figure 3 shows the
simulated results for four alternative controller configurations (Parameters Sets B-E,
Table 1) responding to the same alcohol input (Equation 15). The magnitude and duration
of the predicted excitotoxicity following withdrawal varies considerably among these alter-
native configurations.
Figure 1 Simulated model response to alcohol consumption. (A) The model with Parameter Set A was
simulated with a gradually growing dimensionless alcohol input that approximates three alcohol
consumption peaks per day (as shown in the 24-hour inset) and an abrupt withdrawal after 500 hours. (B)
The resultant controller activity, expressed as number of NMDARs translocated to the synapse per hour. In
response to the changing levels of active, unblocked NMDARs at the synapse, the activity controller (dark
red) moves NMDARs from the extrasynaptic pool to the synapse, while the density controller (navy blue)
removes NMDARs from the synapse. The overall, composite controller activity is shown in grey. (C)
Dynamics of unblocked (red), blocked (blue), and total (purple) NMDARs at the synapse in response to the
alcohol profile shown in Panel A.
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Consumption patterns leading to dependence Do Not influence predicted withdrawal
severity
Clinicians have no control over the alcohol consumption pattern that leads to alcohol
dependence, and frequently the pattern is unknown. In order to gauge the relative im-
port of specific consumption patterns on predicted withdrawal severity, we simulated
four alcohol consumption patterns. We selected Parameter Set E for these investiga-
tions, because, as shown in Figure 3D, this configuration led to moderately severe pre-
dicted withdrawal upon cessation of alcohol input. As shown in Table 2 and the insets
of Figure 4, all four proposed alcohol inputs involve a gradually increasing dimension-
less alcohol level that ends abruptly after 500 hours. The profiles vary in consumption
Table 1 Controller parameter sets
Parameter Set A Set B Set C Set D Set E
ymax1 (rec/hr) 25 25 25 25 25
n1 2 2 4 2 4
ax (rec) 50 50 50 25 25
az (rec) 50 50 50 25 25
ka 0.5 0.5 0.5 0.5 0.5
ymax2 (rec/hr) 25 12.5 25 25 25
n2 2 2 4 2 4
a2 (rec) 100 100 100 50 50
Figure(s) 1,2* 3A 3B 3C 3D, 4, 5
Values of parameters used for various analyses and the figures associated with the corresponding analyses. Bolded
numbers highlight differences from Parameter Set A. *: For each panel of Figure 2, the indicated parameter was altered
from its nominal value in Parameter Set A.
Figure 2 Steady state controller actions for various primary parameter alterations. The number of NMDARs
translocated to the synapse per hour by each controller with various values of ymax (A), n (B), and a (C). In
each panel, the action of the activity controller is positive, changing in response to ΔU, whereas the action
of the density controller is negative and changes according to ΔT. Parameter values were altered in common
intervals across both controllers. For (A), ymax = 5 (red), 10 (orange), 15 (yellow), 20 (green), 25 (blue), and
30 (purple) receptors/hour. For (B), n = 1 (red), 2 (orange), 3 (yellow), 4 (green), 5 (blue), and 6 (purple). For
(C), a= 25 (red), 50 (orange), 75 (yellow), 100 (green), 125 (blue), and 150 (purple) receptors. Parameter values not
explicitly changed are those of Parameter Set A. Increased alcohol concentration decreases the value of
a1, as shown by the open arrow in (C).
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pattern from an idealized linear increase to a randomized pattern of intake. The simu-
lated results of NMDAR levels at the synapse are shown in Figure 4. Interestingly, the
severity of alcohol withdrawal, as quantified by the area under the curve and the max-
imum number of unblocked receptors at the synapse, does not change appreciably
(<10%, Table 2). In fact, as long as the consistency of exposure, peak ethanol concentra-
tion, and withdrawal profile are similar, the severity of withdrawal is largely the same.
This suggests that although withdrawal severity differs considerably with controller pa-
rameters (Figure 3, akin to different activities in different individuals), the specific pat-
tern of alcohol consumption with a given duration prior to withdrawal does not affect
predicted withdrawal severity (Figure 4, Table 2).
Alcohol consumption during withdrawal affects predicted withdrawal severity
During withdrawal, administration of ethanol and other NMDAR antagonists has been
shown to decrease the severity of withdrawal symptoms in humans and rodents and de-
crease excitotoxicity in cultured neurons [28,29]. Unfortunately, the frequency and dos-
age of NMDAR antagonist administration in in-patient settings is driven
symptomatically and administered reactively. Our model provides the opportunity to
try any withdrawal pattern risk-free and evaluate the predicted withdrawal severity,
even patterns that are not easily implemented clinically. This could lead to proactive
administration of antagonist thereby preventing symptoms and excitotoxic damage.
Whereas the alcohol pattern leading to dependence did not influence the quantified
measures of withdrawal appreciably, the alcohol pattern during withdrawal has a large
Figure 3 The magnitude and duration of predicted excitotoxicity varies with controller configuration. In
response to the alcohol input of Equation 15 (shown in Figure 1A), the number of blocked (blue) and
unblocked (red) NMDARs at the synapse varies with controller configuration. Controller parameters are
listed in Table 1: (A) Parameter Set B, (B) Parameter Set C, (C) Parameter Set D, (D) Parameter Set E.
Excitotoxicity is inferred when the number of unblocked receptors at the synapse is greater than 100 (the
arbitrarily defined explicit set point).
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impact on these measures. For the pre-withdrawal alcohol input given in Equation 15
for t < 500 hr, Figure 5 shows the predicted synaptic NMDAR populations during six
withdrawal regimes. These regimes include complete cessation (Figure 5A), exponential
decay (Figure 5B), step-wise decreases (Figure 5C), and linearly decreasing alcohol pro-
files with various initial amounts (Figures 5D-F). The quantified severity of withdrawal
is shown in Table 3. As expected, additional alcohol present during the withdrawal
period decreases the severity of withdrawal, primarily in terms of the area under the
curve. The maximum number of unblocked receptors observed is fairly consistent
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A tð Þ ¼ 0
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p≤0:1 A tð Þ ¼ A t−1ð Þ þ 0:1
p > 0:1 A tð Þ ¼ A tlastð Þe−0:01ðtlast−t
 
Where p is a
randomly generated probability and tlast is the time
alcohol was last consumed.
t≥500
A tð Þ ¼ 0
 
2680 107.77
The corresponding dynamic responses are shown in Figure 4.
Figure 4 The specific pattern of alcohol consumption prior to withdrawal does not affect withdrawal severity. The
number of unblocked (red) and blocked (blue) NMDARs at the synapse for various dimensionless alcohol
consumption patterns (green insets). For periodic increases (A), constantly increasing levels (B), incremental
increases (C), and randomly distributed dimensionless alcohol levels (D), the excitotoxicity after withdrawal is
relatively uniform.
Gutierrez and Staehle Theoretical Biology and Medical Modelling  (2015) 12:8 Page 7 of 15
during all withdrawal regimes tested; we expect this to be a function of the controller
parameters, which were constant for all withdrawal regimes tested here.
We note that the sudden drop in unblocked receptors and peak in blocked receptors
observed in the ramp, step down, and exponential decay profiles may seem counterin-
tuitive; a peak in unblocked receptors is expected to coincide with observed withdrawal
symptoms. However, this behavior is due to the shift from periodic to sustained alcohol
levels. When the alcohol level deviates between large values and zero (as it does at t <
500 hr), the controller activity mimics these changes. Consistent controller response,
however, leads to a large increase in the number of synaptic receptors, but the high etha-
nol level initiating this consistent response means that the receptors are quickly blocked,
and become unblocked gradually as alcohol level diminishes. This suggests that even if it
were possible to maintain a non-zero alcohol level during in-patient withdrawal, the ef-
fects on NMDAR-mediated neuroexcitatory processes would not be favorable.
Limitations and caveats
We are unaware of any experimental data measuring the translocation of NMDARs in
human brain tissue. Therefore, the kinetics shown here are only hypothetical realiza-
tions of our control system hypothesis. Wherever possible, we have attempted to use
dimensionless (e.g. alcohol level) or easily scalable (e.g. ymax) functions and parameters
so that the model could be adapted easily to fit experimental data.
Furthermore, the predicted control actions do not reveal mechanistic information.
For example, it has been established that NMDAR subunit composition changes in re-
sponse to alcohol [6,17,29,35], promoting a removal of NMDARs from the synapse. In
our model, this is represented in the bulk sensing of blocked NMDARs and removal of
receptors by the density subcontroller.
Figure 5 Alcohol levels during withdrawal affect the severity of withdrawal. The number of unblocked (red)
and blocked (blue) NMDARs at the synapse in response to various withdrawal patterns (green insets). The
full time course is shown in (A). The remaining panels show only t > 400 hr, the region inside the dashed
box in (A). The response is identical in all withdrawal schemes at t < 500 hr. Withdrawal was initiated at t =
500 hr in various patterns: (A) abrupt and complete cessation; (B) exponential decrease of alcohol; (C)
gradual incremental decreases; (D) constant decrease from ½ maximum alcohol level; (E) constant decrease
from ¾ maximum alcohol level; (F) constant decrease from maximum alcohol level.
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Finally, we recognize that the severity of alcohol withdrawal cannot be predicted
by the levels of unblocked NMDARs alone. For example, the neuroinhibitory system
(especially GABAA receptors) has been implicated in the brain’s response to alcohol
[1,36,37]. A complete representation of withdrawal would require incorporation of
these additional systems. However, given the excitotoxic nature of the most detri-
mental symptoms of alcohol withdrawal (delirium tremens, seizures, etc.), we have
focused our efforts on describing the neuroexcitatory effects of alcohol via
NMDARs.
Conclusions
In this work, we have developed a computational model based on a negative feed-
back control system hypothesis of NMDAR regulation at the synapse in the presence
of alcohol. We posit that NMDARs are translocated from an extrasynaptic pool to
the synapse by an activity subcontroller in order to maintain a set number of
unblocked, active NMDARs at the synapse. Simultaneously, NMDARs are removed
from the synapse by a density subcontroller to maintain a constant density of total
NMDARs at the synapse. The composite action of the two subcontrollers aims to
maintain glutamatergic signaling even when NMDARs are blocked by ethanol mole-
cules. The proposed composite controller is tunable for a variety of individual re-
sponses or to match any future experimental data, and the resulting model produces
results consistent with qualitative experimental data describing the biophysical
causes of both dependence and withdrawal across a range of values for controller
parameters.
Our results suggest that withdrawal severity is not influenced by the manner in which
alcohol dependence is achieved, provided that the state of dependence is similar. This
suggests that for a particular individual (analogously, a particular set of controller pa-
rameters), the prediction of withdrawal severity depends on the characterization of the
current state of dependence (frequency, quantity, and duration of alcohol consumption)
and the specific parameters of the individual’s NMDAR controller activity.
Table 3 Measures of withdrawal severity for the six withdrawal profiles tested
Alcohol profile Withdrawal Profile Area under curve Unblocked max
Equation 15
t≥500










A tð Þ ¼ Amax

















A tð Þ ¼ Amax−0:003 t−twithdrawð Þ
 
19.3 101.11
The corresponding dynamic responses are shown in Figure 5.
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The severity of alcohol withdrawal is, however, influenced by the alcohol input
during withdrawal. This is consistent with experimental results that showed that ad-
ministration of NMDAR antagonists such as ethanol reduce the negative effects of
alcohol withdrawal [8], while the administration of NMDAR agonists such as NMDA
increase the severity of withdrawal symptoms [7,27]. The results of this work show
that the most effective means of reducing excitotoxicity involve exacerbating the re-
sponse with increased total alcohol and then carefully decreasing alcohol levels over
a prolonged period of time. This is not likely to be a viable option clinically. The
model provides tremendous flexibility for conducting in silico investigations of alter-
native withdrawal profiles in order to gain a better understanding of how changes in
the dependence and withdrawal profiles can affect the outcomes of excitotoxic with-
drawal and long-term changes to system dynamics and to generate testable
hypotheses.
Methods
The feedback control system and governing equations
In this study, we consider a compensatory negative feedback control mechanism as a
response to ethanol-induced NMDAR inhibition, as shown in the control system block
diagram in Figure 6. The ultimate control objective here is to maintain normalized
brain function in the presence of ethanol by maintaining a constant level of unblocked
NMDARs (U) at the synapse.
Figure 6 Proposed control system block diagram representation. Synaptic activity resulting from the
glutamatergic signaling of NMDARs is controlled via a dual-action composite controller (blue box). The
activity subcontroller of this composite controller translocates NMDARs from an extrasynaptic pool to the
synapse in response to deviations from the explicit set point number of unblocked synaptic NMDARs. The
activity of this controller is also modulated by the alcohol level. The density subcontroller removes
unblocked NMDARs from the synapse according to the deviation in total NMDARs (blocked and unblocked)
from the set point. The combined activity of the two subcontrollers contributes to a net relocation that
alters the number of unblocked synaptic NMDARs. Unblocked NMDARs can also be blocked by alcohol.
Measurements of the number of unblocked NMDARs and the total number of synaptic NMDARs are then
returned to the controller via a negative feedback loop.
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When ethanol is introduced to the system, unblocked receptors (U) become blocked






where k1 = 0.05 hr
−1 and k2 = 0.03 hr
−1. The number of NMDARs is somehow sensed
or measured by the cell in a process that we have assumed to have a perfect gain and
negligible dynamics, akin to most biological sensors. This information is then processed
by a two-part composite controller, whose combined action, CT(t), changes the number
of unblocked receptors (U) at the synapse. The overall changes in U and B are there-
fore governed by Equations 2 and 3:
dU tð Þ
dt
¼ −k1A tð ÞU tð Þ þ k2B tð Þ þ CT tð Þ ð2Þ
dB tð Þ
dt
¼ k1A tð ÞU tð Þ− k2B tð Þ ð3Þ
Development of a composite controller
In order to achieve bi-directional action, the composite controller must be able to move
receptors to and from the synapse. Previous work by Staehle et al. considered a unidir-
ectional controller with sigmoidal shaped steady state characteristic activity to move
unblocked NMDARs to the synapse [31]. Without a mechanism for reducing the num-
ber of receptors at the synapse, this controller was unable to capture expected behavior
during withdrawal. Therefore, in this study, we have developed a dual-mode, bi-
directional composite controller for modulation of synaptic unblocked NMDARs. One
subcontroller inserts new unblocked NMDARs from an extrasynaptic “pool” based on
current levels of synaptic unblocked NMDARs in an effort to maintain a defined popu-
lation of unblocked receptors; this will be referred to henceforth as the activity control-
ler. The second subcontroller removes unblocked NMDARs from the synapse in an
effort to maintain a fixed number of NMDARs at the synapse. This controller does not
discriminate whether the synaptic receptor is blocked or unblocked in its assess-
ment of synaptic density, but only removes active, unblocked NMDARs from the
synapse. NMDAR receptor trafficking is activity dependent [17] and consequently
the trafficking and localization of receptors blocked by ethanol is inhibited [3,38].
We have therefore assumed that inhibited receptors are inaccessible for the mo-
lecular mechanisms responsible for this. The second subcontroller will be referred
to as the density controller. The dual-mode construction yields two subcontrollers
of the following forms, where C1 controls relocation to the synapse by the activity
controller, C2 controls relocation from the synapse by the density controller, and
CT represents the net control action:
T tð Þ ¼ U tð Þ þ B tð Þ ð4Þ
C1 tð Þ ¼ ymax1
U tð Þn1
U tð Þn1 þ a1 Að Þn1
 
ð5Þ
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C2 tð Þ ¼ −ymax2
T tð Þn2
T tð Þn2 þ a2n2
 
ð6Þ
CT tð Þ ¼ C1 tð Þ þ C2 tð Þ ð7Þ
The control laws hypothesized for this system (Equations 5 and 6) are based on simi-
lar mathematical studies of steady state controller action in biological systems [39-41],
and it is hypothesized that this sigmoidal formulation captures the physical limitations
of biological processes. In these descriptions, ymax represents the maximum controller
action, while a and n are position and shape parameters that shift steady state control-
ler activity plots and change the curvature, respectively.
The controller activity formulation of Equations 5–7 is complicated by the fact that
the two subcontrollers cause significant deviation in the implicit set point. Changes to
the parameters of either controller shifts the number of receptors at which the control-
ler actions are balanced, which is the effective set point for the system. Manipulating
parameters to achieve the desired set point is feasible when only one controller is in-
volved, but with the additional complexity of a second subcontroller, an explicit set
point is required. The formulation utilizing an explicit set point is provided in Equa-
tions 8–11.
ΔU tð Þ ¼ UDesired−U tð Þ ð8Þ
ΔT tð Þ ¼ UDesired−T tð Þ ¼ UDesired−U tð Þ−B tð Þ ð9Þ
C1 tð Þ ¼ ymax1
ΔU tð Þn1
a1 Að Þn1 þ ΔU tð Þn1
 
ð10Þ
C2 tð Þ ¼ −ymax2
ΔT tð Þn2
a2n2 þ ΔT tð Þn2
 
ð11Þ
In this formulation, the controller activity is based upon the deviation of the mea-
sured value from the explicit set point. For this study, we have defined the explicit set
point, UDesired, as 100 receptors. This value is arbitrary and can be scaled according to
biochemical data. We have also assumed that the population of NMDARs in the “pool”
is never limiting and thus the calculated C1 controller activity is always realizable. This
is assumption is valid as long as both controllers are active, and would need to be revis-
ited for scenarios in which the activity of one controller dominates (e.g. approximations
of co-morbid disease states). Furthermore, both controllers are constrained in line with
biophysical limitations on their control actions: C1 has no activity if U(t) >UDesired and
C2 has no activity if T(t) <UDesired.
Finally, we posit that the desired number of unblocked NMDARs at the synapse shifts
in response to alcohol intake. Thus, we redefined the position parameter of the activity
subcontroller, a1, to be a function of blood alcohol content. In general, with smaller
values of a1, small changes in U create large changes in controller output. As a1 in-
creases, larger deviations in U are required to obtain the same controller action. Defin-
ing this parameter as a function of alcohol also allows the relative actions of the activity
and density subcontrollers to drift with alcohol input. To capture the alcohol depend-
ency, we have defined a1 as an Arrhenius function deviation from an initial value, as
shown in Equation 12.
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a1 Að Þ ¼ ax þ aze−kaA tð Þ ð12Þ
The position parameter is defined in this manner so that the controller response is
quick when ethanol content is low but requires larger deviations when alcohol level
increases.
In the development of this control scheme, we have made a number of assumptions
about the glutamatergic neurotransmission system. First, we assume that the overall
glutamate load of these neurons is reasonably constant such that ethanol is the only
stimulus modulating the number of NMDARs required at the synapse. This allows the
disturbances to the system to be described as a single function representing alcohol in-
take. Second, we assume that synaptic activity is primarily a function of receptor popu-
lation and density; the receptor population herein can therefore be considered as a
homogenous population with characteristics of the average composition and activity of
synaptic NMDARs.
Simulation
Two methods were utilized to simulate the model. First, a numerical integration of
Equations 2 and 3 was conducted using Euler’s method in Visual Basic and Microsoft
Excel® with a Δt of 0.1 hrs. This method is required for alcohol intake patterns with dis-
continuities. The system was also simulated by differentiating Equations 10 and 11 to
obtain Equations 13 and 14, and then solving the system of differential equations with




a1 Að Þn1 þ ΔU tð Þn1ð Þ2
a1 Að Þn1ΔU tð Þn1−1 dUdt þ kaaza1 Að Þ







ΔT tð Þn2 þ a2n2ð Þ2
a2







Alcohol was initially represented by a chronically increasing sinusoid with fixed period-
icity and abrupt withdrawal at a specified time tw, as described in Equation 15:
A tð Þ ¼
0
0
Zsin ptð Þ exp gtð Þ
f or





The periodicity parameter, p, describes the frequency of alcohol consumption, g
describes the growth of ethanol consumption over time, tw is the time at which the
desired withdrawal profile is imposed, and Z provides a scaling factor for normalizing
the dimensionless alcohol level. As in our previous work [30,31], we used p = 0.75 hr−1,
g = 5x10−4 hr−1, tw = 500 hr, and Z = 1. Additional alcohol input functions were devel-
oped to investigate the system response to various alcohol dependence and withdrawal
paradigms. These functions are stated and/or illustrated in the Results and Discussion.
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Assessment of predicted withdrawal severity
A primary goal of this study was to identify whether changes in dependence or with-
drawal alcohol profile affect the severity of withdrawal symptoms. In order to quantify
and compare the predicted withdrawal severity under various circumstances with our
theoretical model, we calculated two measures: area under the curve and unblocked
max. The area under the curve was calculated as an approximate integral between the
explicit set point and the actual unblocked receptor curve following the initiation of
withdrawal. This calculation was conducted using a midpoint approximation for all
points after the initiation of withdrawal where the number of unblocked NMDARs was
above the set point. The time step for this approximation was 0.1 hours. This metric
provides insight into the severity of lasting changes in functionality and the number of
synaptic unblocked NMDARs. The peak value of unblocked synaptic NMDARs was de-
termined as the maximum number of NMDARs after the initiation of withdrawal. The
peak value provides insight into the peak glutamatergic activity, or the extent of excito-
toxicity during withdrawal.
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